Atorus™

Atorus isn’t slowing down this November: our OpenVal® Future Forum, PHUSE SDE Cary, the Bay Area Biotech-Pharma Statistics Workshop, and PHUSE EU Connect in Glasgow (booth #33). Book time with us: atorusresearch.com/events/ #DataThatDoes #OpenVal #PHUSE #ClinicalAnalytics #StatisticalProgramming #OpenSource #Rstats

Most teams don't come to us with one simple problem. They come with a gap: environments that feel like two different worlds, data with no clear view of database lock, a portfolio with no data strategy. Which one is yours? #Atorus #OpenVal #Ageirein #ClinicalAnalytics #AnalyticsEngineering #Biometrics #Rstats

One week to go: the OpenVal® Future Forum’s R in Submissions panel brings Eric Nantz, Andy Miskell, and Mike Stackhouse together on challenges in FDA reviews, where sponsors still meet pushbacks, and how to move R forward. Nov 4, free. Save your spot: atorusresearch.com/about/eve… #OpenValFutureForum #DataThatDoes #Atorus #OpenVal #GxP #ClinicalDevelopment #Rstats #OpenSource

Three challenges every team running R in a regulated setting face: documented evidence, reproducibility, and ongoing maintenance. OpenVal® solves all three. atorusresearch.com/openval/ #DataThatDoes #Atorus #OpenVal #OpenSource #GxPValidation #StatisticalProgramming #ClinicalAnalytics #pharmaverse #Rstats

Great conversations at the Veeva R&D and Quality Summit about what happens to clinical data after quality review. Ageirein™ connects with Veeva EDC and DQS so teams can move from review to data analysis in a validated environment. Our crew is in Boston, so let’s connect! #Atorus #Veeva #Ageirein #ClinicalDataManagement #VeevaSummit

R in submissions: What challenges come up in FDA reviews? Where’s the pushback? How is CAMIS building evidence? Hear from Eric Nantz, Andy Miskell and Mike Stackhouse at the OpenVal® Future Forum. Free to join: atorusresearch.com/about/eve… #OpenValFutureForum #DataThatDoes #Atorus #OpenVal #GxP #OpenSource #Rstats

The Atorus crew is headed to the Veeva R&D and Quality Summit in Boston, Oct. 20–21 Let’s talk about how Ageirein™ complements Veeva DQS atorusresearch.com/about/eve… #VeevaSummit #DataThatDoes #Atorus #Ageirein #Veeva #Rstats #ClinicalDataManagement

PHUSE EU Connect in Glasgow is one month out. Don't miss the sessions from Aga Rasinska, Mike Stackhouse, and Frank Menius. atorusresearch.com/about/eve… #DataThatDoes #Atorus #PHUSE #PHUSEEU #StatisticalProgramming #ClinicalAnalytics #OpenSource #GxP #Rstats

The data is in. Now the work shouldn't stall. Ageirein™ links dashboards and reports straight to each study, and Ageirein Flow runs R and SAS® in one automated pipeline, start to finish. atorusresearch.com/inside-th… #DataThatDoes #Atorus #Ageirein #rstats

OpenVal® Future Forum, Nov 4: From Adoption to Submission. Insider Session, 9 a.m. ET / 15:00 CET: customers only. Community Session, 11 a.m. ET / 17:00 CET: free and open to all, with real-world stories, a live Q&A, and an unscripted fireside panel. Register: atorusresearch.com/about/eve… #OpenValFutureForum #DataThatDoes #Atorus #OpenVal #OpenSource #ClinicalProgramming #Rstats

CRF annotation is where trial design intent becomes structured and machine-readable, and AI tools are only as reliable as the inputs they reason over. See the Atorus poster on eCRF Auto-Annotation at PHUSE SDE Copenhagen, Oct 22. atorusresearch.com/about/eve… #DataThatDoes #Atorus #PHUSE #CDASH #ClinicalDataManagement #ClinicalAnalytics #AI #Rstats

From Basel to Denver to San Diego, the Atorus team was right where the conversations were happening. One theme: the industry is rethinking how trial data gets collected, standardized, and flows into analytics. On your agenda too? Let’s talk. atorusresearch.com/contact/ #Atorus #BiotechX #CDISC #CDISCInterchange #MedidataNEXT #ClinicalData

OpenVal® Future Forum, November 4: From Adoption to Submission. Insider session exclusively for customers starts at 9 a.m. ET (15:00 CET). At 11 a.m. ET (17:00 CET), the open session starts and welcomes anyone working with open-source packages in regulated pharma. Details at the link. atorusresearch.com/about/eve… #OpenValFutureForum #DataThatDoes #Atorus #OpenVal #OpenSource #RegulatorySubmissions #Rstats

We handed all 30 CDISC pilot tables to Claude Code. Every table verified twice, numerically and visually. Two R package releases shipped as well. Read the blog: atorusresearch.com/cdisc-pil… #rstats #CDISC #StatisticalProgramming #ClinicalTrials #Atorus

Your team is ready to analyze. The data isn't. Ageirein™ now pulls data directly from Veeva EDC, Veeva DQS, and Medidata Rave, and puts every study file in one place, under the access controls you set. Data flows in, errors stay out. atorusresearch.com/inside-th… #DataThatDoes #Atorus #Ageirein #Rstats

How do you keep R packages validated as open source moves? Because it does, all the time. Read the details: atorusresearch.com/resources… #DataThatDoes #Atorus #OpenVal #rstats

In 2020 we replicated the CDISC pilot in R. Six years on, we handed all 30 tables to Claude Code. So how can tooling like this improve our processes today? Don't miss @mike_at_atorus on the Technical Panel at PHUSE SDE Boston, October 8. atorusresearch.com/about/eve… #DataThatDoes #Atorus #PHUSE #CDISC #StatisticalProgramming #ClinicalAnalytics #OpenSource #Rstats

Eight events, both sides of the Atlantic. All in October. Book time with us: atorusresearch.com/events/ #DataThatDoes #Atorus #ClinicalAnalytics #StatisticalProgramming #ClinicalTrials #OpenSource #Rstats

Save the date. The OpenVal® Future Forum is back on November 4. Dedicated sessions for OpenVal customers, and open sessions for anyone working with open-source packages in regulated pharma. Join us - details soon. #OpenValFutureForum #Atorus #OpenVal #Rstats #OpenSource #ClinicalProgramming

At posit::conf(2026) last week, Jon Harmon won Community Builder at the first Impact Awards for the Data Science Learning Community: a free weekly #TidyTuesday dataset and a Slack team 23,000 members strong. Jim Doyle got his reaction at the booth. #DataThatDoes #Atorus #RShiny #PositConf #PositConf2026 #Posit